Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.215
-0.495 (-18.27%)
At close: May 13, 2025, 4:00 PM
2.250
+0.035 (1.58%)
After-hours: May 13, 2025, 7:59 PM EDT
Adverum Biotechnologies Market Cap
Adverum Biotechnologies has a market cap or net worth of $46.27 million as of May 13, 2025. Its market cap has decreased by -75.74% in one year.
Market Cap
46.27M
Enterprise Value
16.99M
1-Year Change
-75.74%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $46.27M, a decrease of -92.04%. That is a compound annual growth rate of -20.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 46.30M | -52.32% |
| Dec 31, 2024 | 97.10M | 27.60% |
| Dec 29, 2023 | 76.10M | 31.66% |
| Dec 30, 2022 | 57.80M | -66.53% |
| Dec 31, 2021 | 172.70M | -83.66% |
| Dec 31, 2020 | 1.06B | 42.01% |
| Dec 31, 2019 | 744.10M | 275.81% |
| Dec 31, 2018 | 198.00M | 25.63% |
| Dec 29, 2017 | 157.60M | 30.25% |
| Dec 30, 2016 | 121.00M | -50.65% |
| Dec 31, 2015 | 245.20M | -79.79% |
| Dec 31, 2014 | 1.21B | 108.67% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |